In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 2.05 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price level of $75.76 trading at -$0.67 or -0.88% at ring of the bell on the day assigns it a market valuation of $8.35B. That closing price of VKTX’s stock is at a discount of -31.22% from its 52-week high price of $99.41 and is indicating a premium of 89.07% from its 52-week low price of $8.28. Taking a look at company’s average trading volume volume of 6.52 million if we extend that period to 3-months.

Viking Therapeutics Inc (NASDAQ:VKTX) trade information

Upright in the red during last session for losing -0.88%, in the last five days VKTX remained trading in the green while hitting it’s week-highest on Wednesday, 05/01/24 when the stock touched $75.76 price level, adding 5.75% to its value on the day. Viking Therapeutics Inc’s shares saw a change of 307.09% in year-to-date performance and have moved 10.02% in past 5-day. Viking Therapeutics Inc (NASDAQ:VKTX) showed a performance of -3.42% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.89% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -21.98% while estimates for its earnings growth in next 5 years are of 40.00%.

VKTX Dividends

Viking Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.